Why It Matters
The January 8, 2026 House Science, Space, and Technology Committee hearing on "Chemistry Competitiveness: Fueling Innovation and Streamlining Processes to Ensure Safety and Security" addresses critical threats to American economic and national security.
The Stakes:
U.S. basic science funding has plummeted from 1 percent of GDP in the 1970s to 0.1 percent today, while China’s research investment increased 500% since 1996. Major industry players—the American Chemistry Council, Chevron Phillips Chemical, Lubrizol Corp., and the National Association of Manufacturers—are lobbying for R&D tax credits, regulatory streamlining under the Toxic Substances Control Act (TSCA), and favorable trade policies.
Chemical manufacturers face mounting pressure between innovation demands and regulatory burdens. Rep. Jay Obernolte, the Research and Technology Subcommittee chairman, views the hearing as critical to maintaining U.S. science and technology leadership amid bipartisan concern that American chemical industry dominance continues eroding to foreign competitors.
Broader Context
The hearing reflects alarm over America’s declining scientific leadership. China now controls 44 percent of global chemical production while rapidly advancing into higher-value specialty chemicals. Meanwhile, the U.S. sector faces a down cycle with production growth forecasts dropping to just 1.9-2% through 2026.
Key policy challenges include proposed federal R&D cuts of up to 34 percent TSCA regulatory uncertainty, tariff volatility forcing supply chain disruptions, and the Chemical Facility Anti-Terrorism Standards program’s unresolved statutory authority since 2023.
Rep. Bill Foster champions the American Innovation Act to address declining research investment, while Obernolte ties innovation directly to economic and national security priorities. Industry stakeholders have intensified lobbying on competitiveness, regulatory streamlining, and tax incentives.
The Agenda
The hearing will feature chemical industry and allied sector witnesses, with likely representation from key stakeholders including the American Chemistry Council, which spent $50,000 quarterly throughout 2024-2025 lobbying on competitiveness and security issues, and Chevron Phillips Chemical, which escalated spending to $50,000 quarterly by mid-2025.
Congressional leadership includes Rep. Bill Foster (D-IL-11), who sponsored the American Innovation Act, and Rep. Jay Obernolte (R-CA-23), who has championed innovation as "the engine of our economy and the key to our national security."
Between The Lines
The hearing demonstrates strong bipartisan consensus on chemistry’s strategic importance. Foster has emphasized the urgency of declining U.S. research funding compared to China’s rapid gains, while highlighting chemistry’s national security role.
Obernolte committed to advancing policies supporting cutting-edge research to ensure U.S. leadership—directly aligned with the hearing’s competitiveness focus. Both lawmakers link science and technology to national prosperity and security, creating a bipartisan foundation for policy action.
Competitive Landscape
Industry organizations are mounting coordinated lobbying efforts aligned with the hearing’s agenda. The National Association of Manufacturers deployed $1.68 million in Q1 2025 addressing chemical tax repeal, TSCA implementation, and competitiveness concerns. Lubrizol Corp. spent $50,000 quarterly on manufacturing regulations and R&D tax issues.
Industry priorities center on tax incentives, regulatory streamlining under TSCA, CFATS reauthorization, and favorable trade policies, though no specific bills are referenced in hearing materials.
The Bottom Line
The hearing arrives at a critical inflection point for U.S. chemistry competitiveness. Industry seeks policy support to counter Chinese advances while navigating economic headwinds, even as federal research funding faces significant proposed cuts. The core tension lies between industry’s immediate priorities—regulatory streamlining, tax incentives, and security standards—and longer-term investment needed to maintain global leadership. Bipartisan interest suggests potential for legislative action, but success depends on reconciling competing demands amid budget pressures and trade uncertainty.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article